Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

My last article focused on the near-term risk and return prospects of Altria Group and the thesis was it presents a perfect setup for a long call play.

Altria Group: A 11% Yield Bond With Coupon Growth In Disguise

AbbVie

Dow Inc

Kinder Morgan

Lumen Technologies

SPDR Portfolio S&P 500 High Dividend ETF

Western Union

There are 80 companies in the S&P 500 High Dividend Index ETF. Here are seven dividend stocks to buy from this exchange-traded fund that yield at least 4%.

7 S&P 500 Dividend Stocks To Buy Yielding 4%

Enbridge

Omega Healthcare Investors

Some companies pay big-time dividends for holding their stock. These three will pay you 6% or more.

3 Stocks to Buy With Dividends Yielding More Than 6%

British American Tobacco

Philip Morris

Vaping stocks are doing stock hot on Thursday as the U.S. Food and Drug Administration prepares to weigh in on e-cigarettes. The post Vaping Stocks: BTI, MO and PM Slip Ahead of FDA E-Cigarette Decisions appeared first on InvestorPlace.

Vaping Stocks: BTI, MO and PM Slip Ahead of FDA E-Cigarette Decisions

Turning Point Brands

The Food and Drug Administration (FDA) is expected to make a critical ruling on vaping on Thursday that could potentially create some extreme volatility among tobacco and cannabis stocks. FDA Ruling Imminent: The FDA is expected to issue new rules restricting or completely banning millions of e-cigarette products.

Tobacco Stocks Volatile Ahead Of Key FDA Vaping Ban Decision

Bristol-Myers

Lockheed Martin

LyondellBasell Industries

Merck

Star Bulk Carriers

Teekay LNG Partners

ViacomCBS

The portfolio is listed showing available M* fair values, 2021 dividend, dividend yield, and other metrics to reveal a list of 12 finalists and 9 winner buy candidates. Portfolio value up ~0.7% and 16.8% YTD with dividend yield stable @ 4.19%.

Rose 93 Stock Portfolio August Update, Morning Star Fair Values And Buy Candidate List

Enterprise Products Partners

Energy Transfer LP Unit

Goldman Sachs BDC

Medical Properties Trust

PIMCO Corporate & Income Opportunity Fund

Southern Company

Starwood Property

After 27 weeks and $2,700, the Dividend Harvesting Portfolio is generating $184.67 in estimated annual income and $15.39 in monthly estimated income. In week 27 I added to Goldman Sachs BDC (GSBD), British American Tobacco (BTI), PIMCO Corporate & Income Opportunity Fund (PTY), and Kinder Morgan (KMI).

Dividend Harvesting: Week 27 Update, $2,700 Invested, $184.67 In Annual Dividends Yielding 6.73% With 46 Positions

Clorox

Sturm, Ruger & Company

These three companies are contrarian stocks that could pay off big for patient investors.

3 Top Value Stocks to Buy in September

Raytheon Technologies

Walgreens

The market's red hot streak continues, with 12 record highs in August.

3 Dividend Aristocrats You Can Buy That Are Set To Fly

At recent prices, Altria has a generous 7.3% dividend yield. Due to a large debt position, the dividend growth story hinges on Altria's ability to sustain its underlying growth.

Is Altria A Good Dividend Stock? No, And A Critical Look At The Cannabis Thesis

Take the dividend, write a covered call and hope for capital appraisal while sitting on one of the most defensive blue chips out there. Assumptions on capital appreciation based on DDM.

Altria: Short-Term Trading Idea Before Next Dividend Ex-Date

Ares Capital

Dorchester Minerals

Japan Tobacco Inc

Main Street Capital

Sixth Street Specialty Lending

Higher inflation means your money needs to double faster. To win the war against inflation, you need high yields. Money today is more valuable than money tomorrow.

Good News For Retirees: 3 Big Dividends To Double Your Income Stream

Barrick Gold

JD.com

AT&T

These contrarian stocks can outperform the markets while headwinds wane, as they are fundamentally strong stocks at attractive valuations. The post 4 Contrarian Stocks to Bet on in Seemingly Overvalued Markets appeared first on InvestorPlace.

4 Contrarian Stocks to Bet on in Seemingly Overvalued Markets

Altria (MO) is gaining from rising popularity of IQOS and on!. Strong pricing for tobacco products is also driving revenue growth.

Altria (MO) Benefits From Low-Risk Products, High Pricing

Coca-Cola

Owl Rock Capital Corp

Global X NASDAQ 100 Covered Call ETF

abrdn World Healthcare Fund 

Exxon Mobil

After 26 weeks and $2,600, the Dividend Harvesting Portfolio is generating $177.59 in estimated annual income and $14.80 in monthly estimated income. In week 26, I added Owl Rock Capital Corporation to the Dividend Harvesting portfolio and added an additional share to AT&T, QYLD and THW.

Dividend Harvesting: Week 26 Update, $2,600 Invested, 46 Positions, 6.75% Yield And $177.59 In Annual Dividends

Cornerstone Strategic Value Fund Inc

Cornerstone Total Return Fund Inc

Chevron

Kraft Heinz

KNOT Offshore Partners

LTC Properties

M&T Bank

People's United Financial

Global X Russell 2000 Covered Call ETF

United Bankshares

July 27-August 30, 2021 readers mentioned 40 equities in their comments. Some lamented bad-news, some bad-news investments (rogues) mixed with (mostly) favorites. (Hence, these are the ReFa/Ro.). Ten analyst-target-estimated TOP-NET-GAIN reader faves & rogues, LTC, MTB, LMT, T, XOM, UBSI, KHC, PBCT, CVX, & EPD averaged 26.43% net gains from data collected 8/30/21.

40 Reader Favorites And Rogues 7/23-8/30/21 Reveal 18 Ideal Dividend Dogs, Ready To Run

Altria raised its dividend by 4.9%, adding to its history as a Dividend King. Altria's dividend growth may fight against the insidious effects of inflation.

Altria Group's 7.2% Yield Is Cheap

Archer-Daniels-Midland Company

Church & Dwight

Energizer Holdings

While everyone's keeping their fingers crossed, if the pandemic nevertheless worsens, these consumer goods stocks may do well. The post 7 Consumer Goods Stocks To Buy if the Pandemic Worsens appeared first on InvestorPlace.

7 Consumer Goods Stocks To Buy if the Pandemic Worsens

Constellation Brands

And there will likely be many more to come.

3 Big Names That Have Invested in the Cannabis Industry

Quarterly payout raised to $0.90 per share.

Altria: Another Strong Dividend Raise

News for Altria Stock (MO)